# On the Role of MRI Sequences in Cross-Dataset Generalization for Brain Tumor Segmentation

arXiv: https://arxiv.org/abs/2608.29944 · HTML: https://mlsanity.com/paper/2608.29944/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 5 of its 16 references that are in the map.
- First posted on arXiv 30 Aug 2026.

## Builds on (most cited first, 5 of 5)

- [U-Net: Convolutional Networks for Biomedical Image Segmentation](https://mlsanity.com/paper/1505.04597/) (2015)
- [Identifying the Best Machine Learning Algorithms for Brain Tumor Segmentation, Progression Assessment, and Overall Survival Prediction in the BRATS Challenge](https://mlsanity.com/paper/1811.02629/) (2018)
- [The 2024 Brain Tumor Segmentation (BraTS) Challenge: Glioma Segmentation on Post-treatment MRI](https://mlsanity.com/paper/2405.18368/) (2024)
- [Segmenting Medical Images: From UNet to Res-UNet and nnUNet](https://mlsanity.com/paper/2407.04353/) (2024)
- [DACov: A Deeper Analysis of Data Augmentation on the Computed Tomography Segmentation Problem](https://mlsanity.com/paper/2303.05912/) (2023)

## Abstract (arXiv)

Brain tumor segmentation in magnetic resonance imaging (MRI) is a critical task for diagnosis and treatment planning. Despite the success of deep learning architectures such as U-Net and its variants, performance degradation across datasets remains a major challenge, particularly under domain shift and limited annotated data. To address this issue, this study systematically evaluates how individual MRI sequences influence model robustness across two well-known datasets. A ResUNet-based framework is employed, where each modality is trained independently to isolate its effect under a controlled cross-dataset evaluation protocol with tumor size stratification, without target-domain training, or with limited domain adaptation. Results show that the T2f/FLAIR sequence achieves the best cross-dataset performance, with Dice scores exceeding 75%. It consistently outperforms other modalities across most tumor size ranges, while multi-sequence training further improves performance. Additionally, even limited target-domain adaptation yields rapid initial gains, reducing the need for extensive annotations and costly retraining. Our source code is publicly available at https://github.com/henrique-zan/brain_tumor_segmentation/.